Medical Condition News

RSS

FDA grants orphan drug status to America Stem Cell's ASC-101

America Stem Cell, Inc. announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to ASC-101 to improve homing to bone marrow in patients receiving hematopoietic stem cell transplantation.

30 Mar 2011

New stereo-EEG method can detect epileptic foci during surgeries

The neurosurgery department of HUCH has started to utilize stereo-EEG method for localizing the epileptic focus in severe epilepsy for epilepsy surgery purposes. The department is also getting ready to introduce the so-called deep brain stimulation therapy in the treatment of epilepsy.

30 Mar 2011

GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, announced today new results from three studies that demonstrate the positive effects of the EndoBarrier Gastrointestinal Liner on type 2 diabetes, weight loss and other metabolic factors.

30 Mar 2011

Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy

News outlets report on the political dilemma involved with Provenge — a cancer drug — as well as the impact that Makena — the medicine that can prevent preterm births — could have on the nation's high health care costs.

30 Mar 2011

Study: Skills-training can enhance supportive responses to traumatic abuse disclosures

New research from the University of Oregon concludes that even brief training can help people learn how to be more supportive when friends and family members disclose traumatic events and other experiences of mistreatment.

30 Mar 2011

Women can benefit from Ontario's breast cancer screening program

The Ontario Budget has taken a step toward providing the type of expanded screening for breast cancer that Ontario women need, the Canadian Breast Cancer Foundation —Ontario Region says.

30 Mar 2011

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

The simple practice of letters and a telephone call to patients who are due for a colonoscopy significantly improves adherence to endoscopic follow-up recommendations, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

30 Mar 2011

Nanotechnology-based biosensor may allow early cancer, pathogen detection

A nanotechnology-based biosensor being developed by Kansas State University researchers may allow early detection of both cancer cells and pathogens, leading to increased food safety and reduced health risks.

30 Mar 2011

California's aging LGB more likely to suffer from certain chronic conditions

Members of California's aging lesbian, gay and bisexual population are more likely to suffer from certain chronic conditions, even as they wrestle with the challenges of living alone in far higher numbers than the heterosexual population, according to new policy brief from the UCLA Center for Health Policy Research.

30 Mar 2011

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Silence Therapeutics plc a leading global RNA interference therapeutics company, announces that interim data from its ongoing Phase I clinical study of Atu027, the Company's lead internal therapeutic candidate, have been accepted for poster presentation at the 2011 American Society of Clinical Oncology Annual Meeting.

30 Mar 2011

CancerForward announces new national outreach and partnering program

CancerForward: The Foundation for Cancer Survivors today announced the creation of ConnectToForward, a fundamental initiative of the Foundation's three-prong mission to connect, educate and share information among cancer survivors through its website, cancerforward.org.

30 Mar 2011

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

The results from a new CIGNA study support that there is a potential association between treated periodontal disease and reduced medical costs for patients with diabetes.

30 Mar 2011

Merck submits Erbitux indication extension to EMA for NSCLC treatment

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an indication extension to the European Medicines Agency for the approval of Erbitux in combination with standard 1st line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer with high epidermal growth factor receptor expression.

30 Mar 2011

Pathfinder cell-based therapy reverses diabetes in mouse model

Pathfinder, LLC, a private biotechnology company focused on the treatment of diseases characterized by organ-specific cell damage, today announced publication of promising preclinical data demonstrating that the Company's unique cell-based therapy is able to completely reverse diabetes in a mouse model.

30 Mar 2011

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

Dr. Sube Banerjee, one of the world's leading experts on Alzheimer's disease is the recipient of an international award for the best evidence-based psychosocial intervention for people with dementia and their caregivers.

30 Mar 2011

Vexim granted FDA approval for COHESION bone cement

Vexim specialises in medical instruments and the minimally invasive treatment of vertebral fractures. The company recently announced that it had been awarded FDA certification for its flagship product COHESION™, a bone cement for injection into the vertebra for its fixation following minimally invasive spine repair with the company's SpineJack® device, or following conventional vertebroplasty.

30 Mar 2011

Valeant receives European Commission marketing authorization for Trobalt

Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.

30 Mar 2011

Navy sonar experts develop new medical device for stroke detection

A medical device developed by retired U.S. Navy sonar experts, using submarine technology, is a new paradigm for the detection, diagnosis and monitoring of stroke, says a team of interventional radiologists at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

Attacks by specific type of immune cells cause inflammations of heart muscle

Scientists of the German Cancer Research Center, jointly with colleagues in the United States, have found out that inflammations of the heart muscle are caused by attacks of a specific type of immune cells. These immune cells attack the body's own tissue because during their maturation they did not have the chance to develop tolerance against a protein that is only found in the heart muscle.

30 Mar 2011

Stanford pediatrics receives Genzyme/ACMG award for biochemical genetic research

Anna-Kaisa Niemi, MD, Ph.D., a resident in Medical Genetics in the Department of Pediatrics, Division of Medical Genetics at the Stanford University Medical Center, in Stanford Calif., was honored as the 2011-2012 recipient of the Genzyme/American College of Medical Genetics Foundation Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2011 Annual Clinical Genetics Meeting in Vancouver, BC, Canada.

30 Mar 2011

Medical Condition News

FDA grants orphan drug status to America Stem Cell's ASC-101

New stereo-EEG method can detect epileptic foci during surgeries

GI Dynamics announces positive results from EndoBarrier studies against type 2 diabetes

Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy

Study: Skills-training can enhance supportive responses to traumatic abuse disclosures

Women can benefit from Ontario's breast cancer screening program

New system can improve patient adherence to colonoscopy recommendations, reduce disparities

Nanotechnology-based biosensor may allow early cancer, pathogen detection

California's aging LGB more likely to suffer from certain chronic conditions

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

CancerForward announces new national outreach and partnering program

New study: Periodontal therapy can help reduce medical costs for patients with diabetes

Merck submits Erbitux indication extension to EMA for NSCLC treatment

Pathfinder cell-based therapy reverses diabetes in mouse model

ADI, Fondation Médéric Alzheimer honor Britain's psychiatry professor with international award

Vexim granted FDA approval for COHESION bone cement

Valeant receives European Commission marketing authorization for Trobalt

Navy sonar experts develop new medical device for stroke detection

Attacks by specific type of immune cells cause inflammations of heart muscle

Stanford pediatrics receives Genzyme/ACMG award for biochemical genetic research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News